Related Experiment Video
Updated: Aug 12, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
Proximal versus distal protection: dissecting clinical trials
Vincenzo Fioretti1, Donato Gerardi1, Giampaolo Luzi2
1Division of Cardiology, Cardiovascular Department, San Carlo Regional Hospital, Potenza, Italy.
Minerva Cardiology and Angiology
|January 26, 2023
Summary
Carotid artery stenting (CAS) uses embolic protection devices (EPDs) to prevent stroke. This review examines various EPDs, finding no clear superiority among current options for preventing embolization during CAS procedures.
Area of Science:
- Interventional cardiology and neurovascular interventions.
- Medical device technology and clinical application.
- Cerebrovascular disease management.
Background:
- Carotid artery stenting (CAS) is an alternative to carotid endarterectomy for stenosis.
- Distal embolization during CAS is a major concern, potentially causing stroke.
- Embolic protection devices (EPDs) are recommended to mitigate this risk.
Approach:
- Review of available embolic protection devices (EPDs) for CAS.
- Examination of proximal protection devices (PPDs) and distal protection devices (DPDs).
- Analysis of innovative devices and techniques, including their strengths and weaknesses.
Key Points:
- EPDs aim to minimize embolization of atherosclerotic debris during CAS.
- Two main categories of EPDs exist: proximal and distal.
- Current clinical evidence does not demonstrate the superiority of one EPD type over another.
Conclusions:
- The review evaluates the evidence and rationale for routine EPD use in CAS.
- Understanding the strengths and weaknesses of different EPDs is crucial.
- Further research may be needed to establish clear clinical superiority of specific devices.
Related Concept Videos
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
156
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:12What is an Experiment?
11.9K
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
11.9K